Anti-UK114 antibodies were found to selectively label and exhibit complement-dependent cytotoxic activity on adeno-carcinoma cells (from colon, lung, breast), but not on normal cells, except for a small fraction of hepatocytes of fetal origin [23]. This evidence concerns the gene RIDA and adenocarcinoma.